Design, synthesis and docking study of 5-amino substituted indeno[1,2-c]isoquinolines as novel topoisomerase I inhibitors

被引:18
作者
Khadka, Daulat Bikram [1 ,2 ]
Quynh Manh Le [1 ,2 ]
Yang, Su Hui [1 ,2 ]
Hue Thi My Van [1 ,2 ]
Thanh Nguyen Le [1 ,2 ]
Cho, Suk Hee [1 ,2 ]
Kwon, Youngjoo [3 ]
Lee, Kyung-Tae [4 ]
Lee, Eung-Seok [5 ]
Cho, Won-Jea [1 ,2 ]
机构
[1] Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea
[2] Chonnam Natl Univ, Res Inst Drug Dev, Kwangju 500757, South Korea
[3] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea
[4] Kyung Hee Univ, Coll Pharm, Seoul 130701, South Korea
[5] Yeungnam Univ, Coll Pharm, Kyongsan 712749, South Korea
关键词
Indeno[1,2-c]isoquinolines; Topoisomerase I; Cytotoxicity; Docking study; DRUG CAMPTOTHECIN; CYTOTOXICITY; 3-ARYLISOQUINOLINES; AGENTS; RING;
D O I
10.1016/j.bmc.2011.01.064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Various 5-amino group-substituted indeno[1,2-c]isoquinolines 7a-f were synthesized based on the previous QSAR study as rigid structures of 3-arylisoquinolines. Amino group-substituted compounds, especially 5-piperazinyl indeno[1,2-c]isoquinoline 7f, displayed potent topoisomerase I inhibitory activity as well as cytotoxicities against five different tumor cell lines. A Surflex-Dock docking model of 7f was also studied. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1924 / 1929
页数:6
相关论文
共 17 条
[1]  
ARNOULD R, 1990, ANTICANCER RES, V10, P145
[2]  
BJORNSTI MA, 1989, CANCER RES, V49, P6318
[3]   Synthesis of new 3-arylisoquinolinamines: Effect on topoisomerase I inhibition and cytotoxicity [J].
Cho, WJ ;
Min, SY ;
Le, TN ;
Kim, TS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (24) :4451-4454
[4]  
Cho WJ, 1999, CHEM PHARM BULL, V47, P900
[5]   Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors [J].
Cho, Won-Jea ;
Le, Quynh Manh ;
Van, Hue Thi My ;
Lee, Kwang Youl ;
Kang, Bok Yun ;
Lee, Eung-Seok ;
Lee, Sang Kook ;
Kwon, Youngjoo .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (13) :3531-3534
[6]   Effects of drug efflux proteins and topoisomerase I mutations on the camptothecin analogue gimatecan [J].
Gounder, Murugesan K. ;
Nazar, Ahamed S. ;
Saleem, Ahamed ;
Pungaliya, Pooja ;
Kulkarni, Diptee ;
Versace, Richard ;
Rubin, Eric H. .
INVESTIGATIONAL NEW DRUGS, 2008, 26 (03) :205-213
[7]  
HSIANG YH, 1988, CANCER RES, V48, P1722
[8]   Protein-linked DNA strand breaks induced by NSC 314622, a novel noncamptothecin topoisomerase I poison [J].
Kohlhagen, G ;
Paull, KD ;
Cushman, M ;
Nagafuji, P ;
Pommier, Y .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :50-58
[9]   Molecular design, synthesis and docking study of benz[b]oxepines and 12-oxobenzo[c]phenanthridinones as topoisomerase 1 inhibitors [J].
Lee, Suh-Hee ;
Van, Hue Thi My ;
Yang, Su Hui ;
Lee, Kyung-Tae ;
Kwon, Youngjoo ;
Cho, Won-Jea .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (09) :2444-2447
[10]   Optimization of the indenone ring of indenoisoquinoline topoisomerase I inhibitors [J].
Morrell, Andrew ;
Placzek, Michael ;
Parmley, Seth ;
Grella, Brian ;
Antony, Smitha ;
Pommier, Yves ;
Cushman, Mark .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) :4388-4404